Q3 2017 Holdings
Filed 2017-11-14 | 45 holdings | $149.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $59.3M | 1,636,124 | 39.8% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $55.7M | 597,972 | 37.3% |
| Catalyst Pharmaceuticals Inc(CPRX) | Common | 14888U101 | $11.7M | 4,635,745 | 7.8% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $9.7M | 429,600 | 6.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | Common | 09058V103 | $9.3M | 1,778,525 | 6.3% |
| Cellectis S A(CLLS) | Sponsored ADS | 15117K103 | $2.2M | 78,289 | 1.5% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $206.1K | 14,739,461 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $97.1K | 6,437,122 | 0.1% |
| Kite Pharma Inc | Common | 49803L109 | $89.4K | 496,983 | 0.1% |
| Array Biopharma Inc(ARRYEUR) | Common | 04269X105 | $65.8K | 5,353,029 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | Common | 189464100 | $64.7K | 785,700 | 0.0% |
| Medicines Co | Common | 584688105 | $63.7K | 1,720,393 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | Common | 695127100 | $49.2K | 1,311,460 | 0.0% |
| Horizon Pharma PLC | Common | G4617B105 | $44.6K | 3,516,100 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $43.4K | 3,710,601 | 0.0% |
| Avexis Inc | Common | 05366U100 | $42.2K | 436,702 | 0.0% |
| Dermira Inc(DERMEUR) | Common | 24983L104 | $41.0K | 1,520,000 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $36.0K | 1,026,368 | 0.0% |
| Global Blood Therapeutics Inc | Common | 37890U108 | $34.9K | 1,124,300 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $32.6K | 4,201,343 | 0.0% |
| Assembly Biosciences Inc | Common | 045396108 | $31.7K | 907,162 | 0.0% |
| Teligent Inc | Common | 87960W104 | $30.7K | 4,578,230 | 0.0% |
| Tesaro Inc | Common | 881569107 | $25.2K | 195,092 | 0.0% |
| Intec Pharma LTD | Common | M53644106 | $19.7K | 2,195,705 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | Common | 921659108 | $17.7K | 988,270 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | Common | 053588109 | $17.5K | 4,806,249 | 0.0% |
| Myokardia Inc | Common | 62857M105 | $17.1K | 398,207 | 0.0% |
| Agenus Inc(AGENEUR) | Common | 00847G705 | $10.8K | 2,459,554 | 0.0% |
| Alimera Sciences Inc | Common | 016259103 | $8.4K | 6,241,581 | 0.0% |
| Amicus Therapeutics Inc(FOLD)Call | Common | 03152W109 | $8.4K | 3,000,000 | 0.0% |
| Veracyte Inc(VCYT) | Common | 92337F107 | $8.2K | 936,909 | 0.0% |
| DBV Technologies S A | Sponsored ADR | 23306J101 | $8.2K | 193,600 | 0.0% |
| Cascadian Therapeutics Inc | Common | 14740B606 | $7.4K | 1,821,248 | 0.0% |
| Immunomedics Inc(IMMU)Call | Common | 452907108 | $6.3K | 875,000 | 0.0% |
| Viveve Medical Inc | Common | 92852W204 | $5.4K | 1,033,276 | 0.0% |
| Pernix Therapeutics Holdings Inc | Convertible Debt | 71426VAK4 | $2.5K | $6,000,000 | 0.0% |
| Ovascience Inc | Common | 69014Q101 | $1.6K | 1,121,952 | 0.0% |
| Array Biopharma Inc(ARRYEUR)Call | Common | 04269X105 | $1.5K | 500,000 | 0.0% |
| Oncobiologics Inc | Common | 68235M105 | $936 | 683,531 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $731 | 66,666 | 0.0% |
| Spdr S&P 500 ETF(SPY)Put | Put | 78462F103 | $469 | 250,000 | 0.0% |
| Oncobiologics Inc - Warrant A | Warrant | 68235M113 | $28 | 233,333 | 0.0% |
| Oncobiologics Inc - Warrant B | Warrant | 68235M121 | $12 | 233,333 | 0.0% |